
PRIA Healthcare is proud to announce its partnership with MedTech Innovator, the world’s largest accelerator for medical device, digital health, and diagnostic companies. This collaboration brings together two organizations with synergistic missions. MedTech Innovator is dedicated to improving patients' lives by accelerating the growth of companies transforming healthcare worldwide. PRIA Healthcare, a leading full-spectrum reimbursement services and market access firm, is committed to accelerating the adoption of healthcare innovation by advocating for consistent and reliable reimbursement. Together, this partnership will empower MedTech companies with the tools and guidance necessary to navigate complex commercialization challenges.
A Commitment to Driving Healthcare Innovation
"We are honored to partner with MedTech Innovator to support the next generation of healthcare innovators," said Jeff Sirek, CEO of PRIA Healthcare. "Reimbursement remains one of the greatest challenges MedTech companies face. By providing strategic guidance and leveraging our expertise, we can help these companies navigate the complexities of coding, coverage, and payment, ensuring that breakthrough technologies reach the patients who need them most. This partnership allows us to align our expertise in reimbursement with MedTech Innovator’s mission of accelerating transformative healthcare solutions, ultimately creating a stronger pathway to market success."
PRIA’s Executive Vice President of Reimbursement, Health Economics, and Market Access, Tonya Dowd, has been an important contributor to the MedTech Innovator Program for many years and instrumental in the advent of this partnership. PRIA’s strategic team, led by Tonya, will be active contributors by reviewing startup applications to identify promising technologies, judging pitch events to assess market viability, and mentoring cohort companies on reimbursement and market access strategies. Additionally, PRIA will provide in-kind services to selected companies, helping them develop their value story to prepare for successful commercialization.
“I’m thrilled to formalize our partnership with MedTech Innovator, which has been at the forefront for shaping the future of medical technology,” said Tonya Dowd. “Having been part of this incredible ecosystem for several years, I’ve seen firsthand how it accelerates innovation and transforms groundbreaking ideas into real-world solutions. This agreement marks an exciting new chapter in our mutual goals to advance MedTech innovation and drive meaningful impact in patient care.”
Partnership Accelerates Innovation
“We are pleased to welcome PRIA to MedTech Innovator as an Innovation Sponsor after several years of collaboration with Tonya Dowd, who has provided mentoring and guidance to many of our startups as they navigate the complicated steps to securing market access,” said Paul Grand, Founder and CEO of MedTech Innovator. “PRIA’s experience working extensively with startup MedTech companies to define a reimbursement pathway for novel procedures will be extremely helpful to our cohort. Our respective organizations share a desire to accelerate healthcare innovation to improve human health, and we look forward to PRIA’s involvement with MTI to achieve this mission.”
For more information on how PRIA Healthcare supports MedTech innovation and commercialization, visit www.PRIAHealthcare.com. To learn more about MedTech Innovator, visit www.MedTechInnovator.org.
PRIA Healthcare is a leading full-spectrum reimbursement services and market access firm, instrumental in the successful commercialization of over 300 medical devices since 2012. As a trusted partner to innovators in MedTech and Life Sciences, PRIA delivers unparalleled expertise to navigate complex reimbursement landscapes.
Our experts in reimbursement strategy and healthcare economics outcomes research provide guidance to medical device companies by navigating challenging and uncertain reimbursement pathways, determining the coding, coverage, and payment for market access and adoption of new technologies. Our strategic approach accelerates the adoption of healthcare innovation, facilitating market access and appropriate reimbursement, today and into the future. PRIA is specialty-agnostic, supporting the entire product journey from concept development to successful commercialization.